Post-market Clinical Trial of the Dominus® Stent-Graft
Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use
- EligibilityCriteria: Inclusion Criteria:  18 years of age or older; Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use; Patient available for appropriate follow-up times for the study duration; Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent.  Exclusion Criteria:  Patient currently participating in another clinical study of drug or medical device; Life expectancy less than 12 months. - HealthyVolunteers: No - Gender: All - GenderBased: Yes - GenderDescription: 18 Years and older (Adult, Older Adult ) - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Patients with Thoracic Aortic Disease treated with the Dominus® Stent-Graft Endoprosthesis. - SamplingMethod: Non-Probability Sample